These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 785695)

  • 1. Fibrin degradation products in renal diseases.
    Kuroyanagi T; Kura K
    Tohoku J Exp Med; 1976 Jul; 119(3):237-44. PubMed ID: 785695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen and FDP-E antigen deposits in nephritic kidneys.
    Nagai T; Kawai C
    Nephron; 1978; 21(1):16-26. PubMed ID: 351448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
    Taira K; Matsunaga T; Kawahara S; Sakamoto S; Kamitsuji H
    Thromb Res; 1989 Feb; 53(4):367-77. PubMed ID: 2929008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin breakdown products and fibrinolysis in renal disease.
    Wardle EN; Taylor G
    J Clin Pathol; 1968 Mar; 21(2):140-6. PubMed ID: 5697045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen/fibrin degradation products in serum of patients with idiopathic thrombocytopenic purpura: elevated levels during severe thrombocytopenic phase of the disease.
    Nagasawa T; Kono I; Sakurai T; Kashiwagi H
    Thromb Haemost; 1976 Jun; 35(3):628-34. PubMed ID: 989969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary fibrinogen and fibrin fragments in children with renal disease.
    Yoshioka K; Iseki T; Akano N; Uraoka Y; Miyata H; Maki S
    Nephron; 1982; 32(2):135-9. PubMed ID: 7177290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of urinary FDP-E measured by latex photometric immunoassay (LPIA) in the renal disease].
    Kaizu K; Ito Y; Uriu K; Komine N; Hashimoto O; Eto S
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):365-71. PubMed ID: 1875556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic split products. A clinicopathological correlative study in adults with lupus glomerulonephritis and various renal diseases.
    Bond RE; Donadio JV; Holley KE; Bowie EJ
    Arch Intern Med; 1973 Aug; 132(2):182-7. PubMed ID: 4719545
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between urinary fibrinogen degradation products and various types of chronic nephritis.
    Sakakibara K; Nagase M; Takada Y; Takada A
    Thromb Res; 1987 Feb; 45(4):403-11. PubMed ID: 3576523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Split products of fibrin in human renal disease.
    Stiehm ER; Trygstad CW
    Am J Med; 1969 May; 46(5):774-86. PubMed ID: 4182522
    [No Abstract]   [Full Text] [Related]  

  • 13. Origin of urinary fibrin-fibrinogen degradation products in renal glomerular disease.
    Hall CL; Blainey JD; Gaffney PJ
    Nephron; 1979; 23(1):6-9. PubMed ID: 450168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin deposits in the glomeruli and fibrin/fibrinogen degradation products (FDP) in the blood and urine in some renal diseases.
    Tishkov I; Tschoukanov C; Doytshinov D; Shipkova P
    Int Urol Nephrol; 1982; 14(1):89-93. PubMed ID: 7118491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in renal function following decreased fibrinogen and raised fibrin degradation products in lupus nephritis with nephrotic syndrome.
    Nagayama Y; Imura H; Muso R
    Scand J Urol Nephrol; 1992; 26(4):387-91. PubMed ID: 1292078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deposition of fibrin-stabilizing factor (F XIIIA and S), fibrinogen-related antigens, fibrinogen degradation products (FDPd and FDPe) and antihemolytic factor (F VIII) in renal disease: analysis of 161 cases by immunofluorescence microscopy.
    Colasanti G; Morel Maroger L; D'Amico G
    Clin Nephrol; 1987 Jul; 28(1):28-34. PubMed ID: 3113791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraglomerular deposition of coagulation-fibrinolysis factors and a platelet membrane antigen in various glomerular diseases.
    Deguchi F; Tomura S; Yoshiyama N; Takeuchi J
    Nephron; 1989; 51(3):377-83. PubMed ID: 2563903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia.
    Bonnar J; McNicol GP; Douglas AS
    Br Med J; 1971 Apr; 2(5752):12-6. PubMed ID: 4994519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lupus nephritis: clinico-immunological correlations based on studies of the complement system, fibrinogen (fibrin) degradation products and PHA-induced lymphocyte transformation].
    Szewczyk Z; Klinger M; Górecka Z; Ratajczak T; Melcer H
    Pol Arch Med Wewn; 1976 Nov; 56(5):419-31. PubMed ID: 1005168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.